Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.46)
# 456
Out of 5,138 analysts
32
Total ratings
64.52%
Success rate
18.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ERAS Erasca | Maintains: Buy | $6 → $11 | $9.56 | +15.06% | 1 | Jan 13, 2026 | |
| STRO Sutro Biopharma | Maintains: Neutral | $2 → $10 | $13.07 | -23.49% | 1 | Dec 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $10 → $4 | $0.55 | +626.08% | 1 | Dec 19, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Buy | $20 → $60 | $36.98 | +62.25% | 2 | Dec 9, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.04 | +356.35% | 2 | Dec 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $25 | $10.50 | +138.10% | 1 | Nov 24, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $1.14 | +514.04% | 1 | Nov 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $40 | $20.67 | +93.52% | 2 | Oct 27, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $8.17 | +389.60% | 2 | Oct 20, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $5.94 | +287.21% | 1 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $105 | $69.26 | +51.60% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $46.53 | -5.44% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $53.07 | +41.32% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $9.20 | +171.74% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.95 | +102.53% | 7 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.11 | +330.53% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $19.26 | +3.84% | 1 | Aug 8, 2025 |
Erasca
Jan 13, 2026
Maintains: Buy
Price Target: $6 → $11
Current: $9.56
Upside: +15.06%
Sutro Biopharma
Dec 22, 2025
Maintains: Neutral
Price Target: $2 → $10
Current: $13.07
Upside: -23.49%
Werewolf Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $10 → $4
Current: $0.55
Upside: +626.08%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $20 → $60
Current: $36.98
Upside: +62.25%
Protara Therapeutics
Dec 3, 2025
Reiterates: Buy
Price Target: $23
Current: $5.04
Upside: +356.35%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $25
Current: $10.50
Upside: +138.10%
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.14
Upside: +514.04%
Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $20.67
Upside: +93.52%
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $8.17
Upside: +389.60%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.94
Upside: +287.21%
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $69.26
Upside: +51.60%
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $46.53
Upside: -5.44%
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $53.07
Upside: +41.32%
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $9.20
Upside: +171.74%
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $3.95
Upside: +102.53%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.11
Upside: +330.53%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $19.26
Upside: +3.84%